naloxegol 12.5 MG Oral Tablet

RxCUI
1551917
RxNorm name
naloxegol 12.5 MG Oral Tablet
Display name
naloxegol 12.5 MG Oral Tablet
Full name
naloxegol 12.5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MOVANTIKNALOXEGOL OXALATEValinor Pharma, LLC28596788-b73f-4247-85fc-3105f51fff5a2025-12-22Warnings, Adverse reactionsExact identifier
rxcui: 1551917
MOVANTIKNALOXEGOL OXALATERedHill Biopharma Ltd300a6474-ebcd-4404-8040-48fdcfcc16352024-11-27Warnings, Adverse reactionsExact identifier
rxcui: 1551917

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
300a6474-ebcd-4404-8040-48fdcfcc1635naloxegol 12.5 MG Oral Tablet [PSN] · naloxegol 12.5 MG Oral Tablet [SCD] · naloxegol 12.5 MG (as naloxegol oxalate 14.2 MG) Oral Tablet [SY]35These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 201420241127
28596788-b73f-4247-85fc-3105f51fff5analoxegol 12.5 MG Oral Tablet [PSN] · naloxegol 12.5 MG Oral Tablet [SCD] · naloxegol 12.5 MG (as naloxegol oxalate 14.2 MG) Oral Tablet [SY]33These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 201420251222